Table 2.
Clinical outcomes of patients
| Derivation cohort | P value | Validation cohort | P value | |||
|---|---|---|---|---|---|---|
| VAT (n = 320) | VAP (n = 369) | VAT (n = 70) | VAP (n = 136) | |||
| Days on mechanical ventilation | 13 (8–20) | 13 (8–26) | 0.35 | 18 (13–29) | 17 (11–29) | 0.23 |
| Days in the ICU | 21 (15–34) | 22 (13–36) | 0.69 | 24 (16 – 37) | 22 (14–35) | 0.3 |
| ICU mortality | 93 (29%) | 146 (40%) | 0.004 | 18 (26%) | 46 (34%) | 0.23 |
| Progression from VAT to VAP | 39 (12%) | – | – | 7 (10%) | – | – |
Data are presented as number (%) or median (interquartile range)
ICU Intensive Care Unit; VAP Ventilator-Associated Pneumonia; VAT Ventilator-Associated Tracheobronchitis
p values < 0.05 are indicated in italics characters